Trade with your broker
Market capitalisation, EUR | 195,377.13 m |
EPS, EUR | 1.93 |
P/B ratio | 5.00 |
P/E ratio | 31.32 |
Dividend yield | 2.22% |
Revenue, EUR | 42,374.42 m |
Net income, EUR | 5,508.28 m |
Profit margin | 13.00% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
Invesco NASDAQ-100 Equal Weight UCITS ETF Acc | 0.98% | Equity Technology Equal Weighted | 101 | 0.20% | 142 | +26.62% | A3EE27 | IE000L2SA8K5 |
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.49% | Equity United States Dividend | 206 | 0.70% | 8 | +26.54% | A2PZMV | IE00BKVKW020 |
WisdomTree Megatrends UCITS ETF USD | 0.07% | Equity World Social/Environmental Innovation | 645 | 0.50% | 36 | - | A3EYCN | IE0000902GT6 |
Invesco EQQQ Nasdaq-100 UCITS ETF Acc | 0.30% | Equity United States Technology | 101 | 0.30% | 2,657 | +36.34% | A2N6RV | IE00BFZXGZ54 |
Invesco Nasdaq-100 ESG UCITS ETF Acc | 0.28% | Equity United States Technology Social/Environmental | 93 | 0.25% | 1,400 | +36.82% | A3CZGT | IE000COQKPO9 |
WisdomTree BioRevolution UCITS ETF USD Acc | 1.18% | Equity World Health Care Social/Environmental Biotech | 89 | 0.45% | 3 | +6.50% | A3CY21 | IE000O8KMPM1 |
iShares Nasdaq 100 UCITS ETF EUR Hedged Acc | 0.30% | Equity United States Technology | 102 | 0.36% | 747 | +28.13% | A2N34W | IE00BYVQ9F29 |
iShares Nasdaq 100 UCITS ETF (DE) | 0.30% | Equity United States Technology | 101 | 0.31% | 4,463 | +36.09% | A0F5UF | DE000A0F5UF5 |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.66% | Equity World Social/Environmental Innovation | 358 | 0.60% | 4 | +20.73% | A3DHPA | IE000VTOHNZ0 |
Xtrackers Nasdaq 100 UCITS ETF 1C | 0.30% | Equity United States Technology | 101 | 0.20% | 894 | +36.47% | A2QJU3 | IE00BMFKG444 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 4.50% | Equity United States Health Care Biotech | 214 | 0.35% | 33 | +24.66% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 4.50% | Equity United States Health Care Biotech | 214 | 0.35% | 444 | +25.65% | A2DWAW | IE00BYXG2H39 |
Invesco Nasdaq-100 UCITS ETF EUR Hedged | 0.30% | Equity United States Technology | 101 | 0.35% | 265 | +28.29% | A2DT9V | IE00BYVTMS52 |
Invesco Nasdaq-100 UCITS ETF CHF Hedged | 0.30% | Equity United States Technology | 101 | 0.35% | 388 | +30.23% | A2JAN0 | IE00BYVTMT69 |
Invesco Nasdaq-100 UCITS ETF GBP Hedged | 0.30% | Equity United States Technology | 101 | 0.35% | 317 | +36.25% | A2JNFA | IE00BYVTMW98 |
Deka Nasdaq-100® UCITS ETF | 0.30% | Equity United States Technology | 101 | 0.25% | 36 | +35.71% | ETFL62 | DE000ETFL623 |
L&G Pharma Breakthrough UCITS ETF | 2.52% | Equity World Health Care Innovation | 37 | 0.49% | 15 | +8.11% | A2H9XR | IE00BF0H7608 |
iShares Nasdaq 100 UCITS ETF (Acc) | 0.30% | Equity United States Technology | 102 | 0.33% | 15,545 | +36.31% | A0YEDL | IE00B53SZB19 |
Invesco EQQQ Nasdaq-100 UCITS ETF | 0.30% | Equity United States Technology | 101 | 0.30% | 7,957 | +35.28% | 801498 | IE0032077012 |
Broker | Rating | Order fee | Stock savings plans | |
---|---|---|---|---|
0.99€ | 1000 | View offer* | ||
1.00€ | 2500 | View offer* | ||
0.00€ | 2500 | View offer* | ||
0.00€ | 500 | View offer* | ||
0.00€ | 400 | View offer* |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
0.00€ | 0.00€ | View offer* | ||
1.50€ 1.50% | 0.00€ | View offer* | ||
1.50€ 1.50% | 0.00€ | View offer* |
YTD | +3.27% |
1 month | -11.85% |
3 months | -18.12% |
6 months | -13.06% |
1 year | +8.58% |
3 years | +25.50% |
5 years | - |
Since inception (MAX) | +50.60% |
2023 | -3.39% |
2022 | +23.35% |
2021 | - |
2020 | - |
Volatility 1 year | 20.14% |
Volatility 3 years | 23.05% |
Volatility 5 years | - |
Return per risk 1 year | 0.42 |
Return per risk 3 years | 0.34 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -25.24% |
Maximum drawdown 3 years | -25.24% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -25.24% |